Climbing the Dose: How Your CGM Changes as You Titrate Up

Nobody starts a GLP-1 at full strength. You begin low and step up every few weeks, which is the stretch where most of the questions pile up. Wearing a CGM through titration turns that uncertain period into something you can actually see. Here's what tends to show up on the sensor as you climb.

Why titration is slow on purpose

The step-up schedule exists to let your body adjust and to keep side effects manageable, mainly the nausea and gut effects that come from slowed digestion. Each dose increase is a small nudge, not a leap. That gradual design is also why your CGM changes tend to arrive in stages rather than all at once.

What often shows up on the sensor, stage by stage

Early on, at the starter dose, many people see only modest changes. The dose is deliberately low, so a mostly-familiar curve is normal and not a sign the drug isn't working.

As the dose steps up, the post-meal peaks are usually where change appears first. Meals that used to send you climbing may start producing lower, rounder curves. Appetite often drops here too, which shifts what and how much you eat, and that shows up on the sensor alongside the drug's direct effect.

At maintenance dose, the pattern you'll live with settles in. This is the point to establish your personal baseline for time in range and steadiness, since it's the profile you'll compare against going forward.

Higher dose doesn't automatically mean steadier

One useful finding to hold onto: the variability-reducing effect of incretin drugs isn't purely a function of dose. In a type 2 diabetes trial, an incretin agent cut glucose swings independently of how much it lowered average glucose (Yoshikawa 2021). The practical read is that chasing the highest dose isn't necessarily the path to the steadiest glucose. The right dose is the one that balances effect and tolerability for you, and your CGM plus your clinician are how you find it.

What to actually watch during titration

Track three things across the weeks. Your post-meal peak heights, and whether they soften as you step up. Your time in range, as a simple week-to-week trend. And any time below range, which matters most if you also take insulin or a sulfonylurea, since those doses may need adjusting as the GLP-1 ramps. Bring the trend, not a single bad day, to your dose-adjustment conversations.